Subject
The Board of Directors approved the consolidated
financial reports of 2020.
Date of events 2021/03/04 To which item it meets paragraph 31
Statement
1.Date of the financial reports submitted to the board of
directors or approved by the board of directors:2021/03/04
2.Date of the financial reports approved by the audit committee:2021/03/04
3.Start and end dates of financial reports of the reporting period
(XXXX/XX/XX~XXXX/XX/XX):2020/01/01~2020/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):8,181,056
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):2,968,803
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):421,232
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):657,640
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):559,500
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):557,365
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):1.88
11.Total assets end of the period (thousand NTD):12,356,914
12.Total liabilities end of the period
(thousand NTD):5,730,055
13.Equity attributable to owners of parent end of the
period (thousand NTD):6,591,677
14.Any other matters that need to be specified:None

Attachments

  • Original document
  • Permalink

Disclaimer

CCPC – China Chemical and Pharmaceutical Co. Ltd. published this content on 05 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 March 2021 07:29:05 UTC.